A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Clinical trial NCT07012395 · RECRUITING

Trial details

NCT number: NCT07012395
Sponsor: Spyre Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis Inflammatory Bowel Diseases Colitis Colitis, Ulcerative

Start date: 2025-05-27
Primary completion: 2027-06-01
Enrollment: 645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.